Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any early-onset non-syndromic cataract in which the cause of the disease is a mutation in the LIM2 gene.
Features include: Nystagmus, Cortical pulverulent cataract, and Amblyopia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Nystagmus, Cortical pulverulent cataract, Amblyopia |
LIM2 encodes lens intrinsic membrane protein 2 (173 aa). Present in the thicker 16-17 nm junctions of mammalian lens fiber cells, where it may contribute to cell junctional organization. Acts as a receptor for calmodulin. Highest expression in Whole Blood (0.5 TPM) and Testis (0.3 TPM).
Cataract 19 multiple types is associated with mutations in the LIM2 gene on chromosome 19.
LIM2 is classified as a druggable target with score 0.0.
Genetic testing for LIM2 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for cataract 19 multiple types.
2 publications have been identified in PubMed for cataract 19 multiple types. Research spans Review / Meta-Analysis (50%) and Gene Therapy / Novel Therapeutics (50%).
Sun HS (2025). [PMID: 39994538](https://pubmed.ncbi.nlm.nih.gov/39994538/). *BMC Ophthalmol*. [Gene Therapy / Novel Therapeutics]
Shiels A (2024). [PMID: 38927721](https://pubmed.ncbi.nlm.nih.gov/38927721/). *Genes (Basel)*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 1:00 AM UTC
Online Mendelian Inheritance in Man